Du sökte efter: genetic analysis
AdjuTec Pharma’s APC148 shines at ESCMID congress
At the recent ESCMID congress, organised by the European Society of Clinical Microbiology and Infectious Diseases, AdjuTec Pharma presented...
Omfattande studie pekar på cannabis potential i cancer
En storskalig metaanalys visar ett tydligt stöd för medicinsk cannabis vid cancerbehandling. Forskarna har granskat över 10 000 studier...
PHI’s acting CEO: ”We aim to drive innovation that accelerates breakthroughs in regenerative medicine”
With the introduction of the HoloMonitor CellSync, Phase Holographic Imaging (PHI) leaps forward in live cell imaging technology. Currently...
Spago takes Tumorad-01 study to the next level
Spago Nanomedical has increased the dose of its cancer drug candidate 177Lu-SN201 in its phase I/IIa Tumorad-01 study, following...
Biovica tecknar Europaavtal
Biovica International har landat ett tungt avtal med franska Eurobio Scientific, som ger bolaget tillgång till 60 procent av...
Alligators vd: ”We are not surprised by the positive readout”
Søren Bregenholt för att få hans kommentarer på de senaste data.
PHI’s acting CEO: ”We aim to drive innovation that accelerates breakthroughs in regenerative medicine”
With the introduction of the HoloMonitor CellSync, Phase Holographic Imaging (PHI) leaps forward in live cell imaging technology. Currently...
TFS boosts neuroscience trials with Nordic data and AI
In an interview with BioStock, Anne-Marie Nagy, PhD, Head of Internal Medicine and Neuroscience at TFS HealthScience, shed light...
AdjuTec Pharma’s CEO: “Our goal is to set a new standard in antibiotic treatment”
Late last year, AdjuTec Pharma launched a phase I clinical trial for its lead candidate, APC148, targeting antimicrobial resistance,...
Biosergens vd: “These findings open up new possibilities”
Biosergens svampdödande läkemedelskandidat, BSG005, fortsätter att visa stark klinisk potential. Majoriteten av patienterna i den andra kohorten återhämtade sig...
Spago’s CEO: “We want to expand cancer treatment with effective radiopharmaceuticals”
2024 has marked a defining chapter for Spago Nanomedical, solidifying its position in radionuclide therapy. By focusing its energy...
PHI’s new CEO: ”I am excited to lead us forward with new energy”
Anders Månsson was recently appointed CEO of Phase Holographic Imaging. With extensive leadership experience in the international life sciences...